Prevalence of Frailty Among People Aged 75 and Over Living at Home

Frailty Clinical Trial

— FRAIL-DOM  

Official title:

Prevalence of Frailty Among People Aged 75 and Over Living at Home

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT05163457
• Other study ID #: 2021-012-FRAIL-DOM
• Status: Completed
• Start date: January 6, 2022
• Est. completion date: February 22, 2022

Study information

• Verified date: March 2022
• Source: Université de Reims Champagne-Ardenne
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The aging of population lead to study ways to prevent dependence. Frailty is a precursor to dependence which can be reversible. In the literature, estimate of prevalence of frailty is highly variable depending on the frailty definition, the population studied and the screan tool used. In fact, many scales to measure frailty have emerged without gold standard.

The SEGAm showed its usefulness in aged patients living at home.

Description:

The aim of the study is to describe prevalence of frailty in patients aged of 75 and more living at home.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 100
• Est. completion date: February 22, 2022
• Est. primary completion date: February 22, 2022
• Accepts healthy volunteers: No
• Gender: All
• Age group: 75 Years and older

Eligibility

Inclusion Criteria:

• male or female

• aged of 75 and more

• living at home

• agreeing to participate in the study

Exclusion Criteria:

• none

Related Conditions & MeSH terms

• Frailty

Intervention

Other:
• Data collection
frailty evaluation

Locations

Country	Name	City	State
France	Maison de Santé Pluridisciplinaire de Bar sur Seine	Bar-sur-Seine	Grand-Est

Sponsors (1)

Lead Sponsor	Collaborator
Université de Reims Champagne-Ardenne

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Frailty	Frailty evaluated using SEGA modified scale (SEGAm). SEGAm includes 13 items (coded from 0 to 2) to obtain a global score out of 26 points. Patients with a score less than or equal to 8 are considered not fragile. Patients with a score between 8 and 11 are considered fragile. Patients with a score greater than or equal to 11 are considered very fragile.	Day 0